Earnings - 8th Sept 2008

4:10PM PAREXEL increases rev guidance in conjunction with the acquisition of ClinPhone and other factors (PRXL) 31.53 +0.94 : The co updates its forward-looking financial guidance for the first quarter of Fiscal Year 2009 and for the full Fiscal Year, in conjunction with the successful completion of the acquisition of ClinPhone and other factors discussed herein. PAREXEL has increased its forward-looking service revenue guidance for the first quarter and Fiscal Year as a result of the positive contributions from the ClinPhone acquisition and a slightly better operating performance, which has been somewhat offset by the negative impact of recent exchange rate movements associated with a much stronger dollar. PRXL sees Q1 EPS of $0.20-0.21, may not be comparable vs $0.25 First Call consensus; revs $270-280 mln, may not be comparable vs $267.81 mln First Call consensus; PRXL sees FY09 EPS of $1.15-1.25, may not be comparable vs $1.20 First Call consensus; sees revs $1.215-1.245 bln, may not be comparable vs $1.15 bln First Call consensus

4:32PM C&D Tech misses by $0.01, misses on revs (CHP) 7.69 +0.26 : Reports Q2 (Jul) earnings of $0.05 per share, $0.01 worse than the First Call consensus of $0.06; revenues rose 11.6% year/year to $92.5 mln vs the $94.3 mln consensus.

4:23PM H.B. Fuller lowers FY08 EPS guidance; sees Q3 revs above consensus, EPS below consensus (FUL) 27.41 +1.03 : Co lowers FY08 EPS to $1.47-1.52, ex $0.08 benefit, vs $1.80 consensus, down from prior guidance of $1.76-1.86. Co issues downside EPS guidance; co sees Q3 EPS of $0.36, ex $0.09 gain, vs $0.48 consensus, sees revs of $362 mln vs $354.2 mln consensus. Co issues downside Q4 guidance; Co sees Q4 EPS of $0.40-0.45 vs $0.56 consensus; sees revs of $380-390 mln vs $365.1 mln consensus. Co says, "We are disappointed that our current outlook indicates that we will fall short of our previous earnings guidance for 2008. However, we believe that this is a temporary situation. We are fully committed to recovering our raw material cost increases over the next several quarters, and are aggressively accelerating our pricing actions. We are also encouraged by positive trends we are seeing in organic sales and the benefits we continue to generate from discretionary cost controls. Despite this temporary setback, we remain focused on building for the future. We will continue to invest for profitable growth, in-line with our strategic five-year plan, as we have throughout this year."

4:11PM Mitcham Ind misses by $0.06, misses on revs; guides FY09 EPS in-line, revs in-line (MIND) 13.59 +0.46 : Reports Q2 (Jul) earnings of $0.17 per share, $0.06 worse than the First Call consensus of $0.23; revenues rose 13.6% year/year to $17.5 mln vs the $17.7 mln consensus. Co issues in-line guidance for FY09, sees EPS of $1.35-1.40 vs. $1.40 consensus; sees FY09 revs of $78-82 mln vs. $78.29 mln consensus.